Laboratory Testing Devices Dominate End-Use Segment of Hemoglobin A1c Testing Devices Market


Posted May 10, 2016 by ranutmr

Hemoglobin A1c test provides the average amount of patient’s glucose levels in last 2 to 3 months, therefore, it is preferred over other conventionally used blood glucose tests.

 
Transparency Market Research has published a report on the global hemoglobin A1c testing devices market. As per the report, the global hemoglobin Alc testing devices market is expected to progress from US$0.9 bn in 2012 to US$1.86 bn by 2019. The report, titled ‘Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global hemoglobin Alc testing devices market is expected to expand at a 10.30% CAGR during the period between 2013 and 2019.

Determining glycated hemoglobin levels assure healthcare professionals about the patient’s blood glucose levels. This test is used for diagnosing and monitoring hemoglobin A1c levels in the diabetic patients. As the A1c test reflects the average amount of glucose for the past two to three months, it is considered to be more reliable than traditional blood glucose tests. Due to increasing incidence of diabetes and growing awareness of better management of diabetes, the global hemoglobin A1c testing devices market is expected to develop rapidly in the years to come. Nowadays, medical professionals usually prescribe HbA1c test over conventional blood glucose tests to patients.

Read More: http://www.transparencymarketresearch.com/hemoglobin-a1c-testing.html

The global hemoglobin A1c testing devices market is segmented on the basis of geography, end use, and technology. By end use, the global hemoglobin A1c testing devices market is classified into laboratory testing devices and point-of-care testing devices. In 2012, the laboratory testing devices segment dominated the global hemoglobin a1c testing devices market. However, the global market for point-of-care testing devices is predicted to develop at a fast pace in the years to come.

Based on geography, the global hemoglobin A1c testing devices market is divided into North America, Asia Pacific, Europe, and Rest of the World. In 2012, the global hemoglobin A1c testing devices market was dominated by North America in terms of revenue. The presence of modern healthcare infrastructure is expected to propel the North America market for hemoglobin A1c testing devices in the years to come. Some of the leading companies operating in the global hemoglobin A1c testing devices market are Abbott Laboratories, Arkray, Inc., Danaher Corporation, Siemens Healthcare, Trinity Biotech plc., Alere, Inc., Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd. With the introduction of innovative hemoglobin A1c testing devices from the new entrants, the global market is expected to be more competitive for the leading players.

By technology, the global hemoglobin A1c testing devices market is classified into ion-exchange, high-performance liquid chromatography (HPLC), immunoassay, boronate affinity chromatography, direct enzymatic assay, and others (micro-optical detection method and capillary electrophoresis). The boronate affinity chromatography segment is predicted to dominate the global hemoglobin A1c testing devices market in the years to come.

Request Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1620

The high cost of hemoglobin A1c testing devices is expected to challenge the development of the global hemoglobin A1c testing devices market. The growth of the hemoglobin A1c testing market is well-supported by its testing results. Increasing geriatric and diabetic populations are expected to propel the global hemoglobin A1c testing devices market during the forecast period.

Key Segments of Global Hemoglobin A1c Testing Devices Market
Hemoglobin A1cTesting Devices Market, by End-use
•Laboratory Testing Devices
•Point-of-Care (POC)Testing Devices

Hemoglobin A1cTesting Devices Market, by Technology
•Ion-Exchange High Performance Liquid Chromatography (HPLC)
•Immunoassay
•Boronate Affinity Chromatography
•Direct Enzymatic Assay
•Others (Micro-Optical Detection Method and Capillary Electrophoresis)

Hemoglobin A1cTesting Devices Market, by Geography
•North America
•Europe
•Asia-Pacific
•Rest of the World (RoW)


About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Country United States
Categories Health , Marketing , Medical
Tags analysis , global , hemoglobin a1c testing devices market , report , research
Last Updated May 10, 2016